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Abstract  
 
Background: Knowledge, perceptions and prescribing behaviour are key to antibiotic prescribing. 
The aim of this paper is to systematically review this. Method: An extensive literature search from 
1990±2014. Results: 19 articles were included; 8 in ambulatory care, 7 in hospital settings, and 4 in 
both, across all countries. Physicians still have inadequate knowledge and misconceptions about 
antibiotic prescribing. Moreover, some physicians although aware that antibiotics are of limited benefit 
in some conditions still prescribed them. Several factors influenced prescribing including SDWLHQWV¶
expectations, severity and duration of infections, uncertainty over diagnosis, potentially losing 
patients, and influence of pharmaceutical companies. Pocket-sized guidelines seen as an important 
source of information for physicians. Conclusion: Inadequate knowledge of prescribing is prevalent 
among physicians. However, many physicians were interested in improving their antibiotic 
prescribing. Multifaceted interventions targeting all key stakeholders including patients are needed to 
improve future antibiotic prescribing. 
 
Key words: antibiotics, irrational use of medicines, patients, prescribing behaviour, physicians, 
systematic reviews, resistance 
 
Introduction 
 
Infectious diseases were the leading cause of morbidity and mortality before the discovery of 
antibiotics. This changed with their advent through researchers including Paul Ehrlich and Alexander 
Fleming, turning once fatal diseases into more manageable health problems (1-4). Advances in 
scientific and medical technology has resulted in the development of new antibiotics as well as 
generic antibiotics, with the latter in particular providing easy accessibility at affordable costs (5). 
Antibiotics are now commonly prescribed to patients in ambulatory care (6-9). However, greater 
accessibility has resulted in irrational and excessive use, leading to increasing antibiotic resistance (5, 
10-14). Increasing antimicrobial resistance is seen as one of the most critical problems facing 
healthcare systems (15), with estimates that antimicrobial resistance (AMR) infections currently cause 
approximately 50,000 deaths a year in Europe and the US alone (1). This increases to several 
hundred thousand deaths each year when other countries are included (1). The continual rise in AMR 
is envisaged to result in 10 million deaths annually by 2050 unless checked. As a consequence, AMR 
infections could be a leading cause of death by 2050. This death rate  will reduce GDP by 2% to 3.5% 
by 2050 and  costing the world up to US$100trillion (1).  Some common infections, especially those 
caused by antibiotic resistant bacteria, are becoming more difficult to treat, causing life-threatening 
illnesses and potentially death (16). The combination of overuse of antibiotics for minor infections, 
misuse and under use due to lack of access and financial support in certain settings, has been a key 
driver of resistance. This phenomenon has been termed selective pressure (15). 
 
Increasing antibiotic resistance  poses a threat to health and healthcare systems in both developed 
and developing countries (17). In high-income countries, continuing high rates of antibiotic use in 
hospitals, the community, and agriculture have contributed to selection pressure that has sustained 
resistant strains (18), forcing a shift to  more expensive and more broad spectrum antibiotics. In low-
income and middle-income countries (LMICs), the high burden of infectious diseases and the 
unregulated access to antimicrobials has resulted in  the emergence of antibiotic resistance (17). This 
is not helped by the increasing use of antibiotics to treat viral upper respiratory tract infections 
(URTIs), inappropriate prescribing of antibiotics for infections such as pneumonia,  purchasing of 
antibiotics without a prescription as well as the challenges involved with determining current 
antimicrobial usage and AMR rates in LMIC countries to provide a baseline for future interventions 
and policies (19-25). Inappropriate use of antibiotics is also not helped by currently limited adherence 
to guidelines among physicians in LMIC countries; greater though among physicians in public (40%) 
than private-for-profit sector facilities at <30% (26). 
 
It is now acknowledged  that the rational use of antibiotics is one of the most important steps to slow 
down the development and spread of resistant bacteria (27). The inappropriate use of antibiotics has 
been attributed to a number of IDFWRUV7KHVHLQFOXGHSK\VLFLDQV¶QRQ-adherence to treatment 
guidelines, lack of knowledge and training regarding  antibiotics, lack of diagnostic facilities, 
uncertainty over the diagnosis, pressure from pharmaceutical industry, fear of clinical failure, financial 
benefits for physicians, pressure from patients to prescribe antibiotics regardless of the indication 
coupled with lack of time of physicians to educate patients. In LMIC countries, there are also concerns 
with the extent and implementation of regulations surrounding the dispensing of antibiotics including 
self purchasing (19, 21, 24, 25, 28-34). Moreover, antibiotic misuse or overuse has promoted the 
perception among the public that these medicines are the preferred treatment for instance for URTIs. 
This in turn induces patients to demand antibiotics, hastening the growth of resistant bacteria (25, 30, 
35). To help combat the irrational use of antibiotics, stringent diagnostic criteria for URTIs have been 
recommended by the Centers for Disease Control and Prevention (CDC) in collaboration with the 
American academy of Paediatrics (AAP) and the American Academy of Family Physicians.  In United 
Kingdom, the National Institute for Health and Clinical Excellence (NICE) introduced in 2008 a 
guideline for antibiotic prescribing in respiratory tract infections. Despite these efforts and guidelines, 
physicians still manage URTIs with considerable variation (19, 20, 30, 36-38).  
 
Consequently, a better understanding of the determinants of antibiotic prescribing among physicians 
is essential for introducing and implementing  targeted interventions to reduce future antibiotic 
prescribing and potential resistance (17, 20, 21, 26), with physician prescribing behaviour playing a 
key role in the utilisation of antibiotics (39). Hence, adequate knowledge and appropriate education 
DUHHVVHQWLDO3K\VLFLDQV¶XQGHUVWDQGLQJRIZKHQDQWLELRWLFVDUHQHHGHGDQGPRUHLPSRrtantly when 
they are not, should subsequently reduce their prescribing (40, 41). However, there will be challenges 
especially in LMIC countries (19, 21, 33, 34, 42). 
 
6LQFHFKDQJHVLQSUHVFULEHUV¶NQRZOHGJHDQGEHKDYLRUDUHSUHUHTXLVLWHIRUFKDQJHVLQDQWLELRWLF
prescribing pattern, it is important to understand what physicians know about antibiotics, how they 
acquire and maintain their knowledge, and what factors influence their prescribing practice. 
UQGHUVWDQGLQJSUHVFULEHUV¶SHUVSHFWLYHVFRXOGOHDGWRWKHGHYHORSPHQWRIPRUHHIIHFWLYHLQWerventions 
and strategies to promote the rational use of antibiotics. Consequently, the aim of this paper is to 
systematically review the knowledge, perceptions, and behavior of physicians regarding antibiotic 
prescribing to guide future strategies. 
 
Methodology 
 
An extensive literature search was performed to identify published studies related to medical 
SUDFWLWLRQHUV¶SHUFHSWLRQVNQRZOHGJHDWWLWXGHSUDFWLFHEHOLHIDQGEHKDYLRXUUHJDUGLQJDQWLELRWLF
prescribing and antibiotic use. The search strategy was to identify cross-sectional observational 
studies and experimental studies; applied either qualitative or quantitative methods or both. PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement and guidelines 
were followed when performing the search and the identification of possible studies (43).  
 
Relevant studies were identified by a comprehensive search of several electronic databases. These 
included Scopus, PubMed, ISI Web of Knowledge, Proquest, Science Direct online library and Google 
Scholar. The bibliography of the retrieved studies was also checked for potential studies. The search 
strategy involved using Boolean operators for combinations of several keywords to identify the 
relevant articles. The key words used in the search included (antibiotic(s) OR antimicrobials) AND 
(prescribing OR resistance) AND (knowledge OR practice) AND (attitude OR perception). For 
prescribers, the following keywords were used: prescriber(s), general practitioner(s), doctor(s) and 
physician(s). Articles related to antibiotic use in dental practices were excluded from the systematic 
review.  We acknowledge that particularly in LMIC countries the prescribing and dispensing may be 
undertaken by non-physicians, e.g. pharmacists, even when this is not permitted (21, 44). However, 
these papers have been excluded from the review as our focus was on physicians.  
 
To make the review relevant to current practice, the search was restricted to the studies published 
between 1990 and 2014. Only articles published in the English language were included. All results 
were listed and evaluated by reading the abstracts. To determine whether the studies met the 
required criteria, the lists of titles and abstracts from the searches were examined by two researchers 
independently. Where doubt remained, the full article was examined by two of the researchers to 
determine whether it is relevant, with the final inclusion of the article undertaken in a consensus 
meeting involving the authors.  
 
The methodology, including summarizing the quality and limitations of studies, follows previously 
published studies (45-47).  
 
Results 
 
The search process resulted in 1633 titles and abstracts. After removing duplicates, 1052 studies 
were screened, of which 764 were excluded on the basis of title. Further assessment of title and 
abstracts led to the identification of 145 studies not meeting eligibility criteria, as they were not related 
to the topic and did not investigate perceptions, attitude or knowledge of the prescribers towards 
antibiotics. The remaining (n= 143) were full-text assessed for eligibility for inclusion in the study. 
Seventy eight studies were then excluded as their main findings did not discuss issues related to our 
UHYLHZREMHFWLYHV$IXUWKHUVWXGLHVZHUHH[FOXGHGDVWKH\GLGQRWDVVHVVSK\VLFLDQV¶SHUFHSWLRQV
and knowledge, but rather looking at the prescribing patterns and variability in antibiotic usage. This 
left 19 articles for inclusion in the review (Table 1).  
 
Insert Table 1. 
 
The PRISMA diagram for this review is shown in Figure 1.  
 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The PRISMA Diagram (The template is adapted with modification from Moher et al. 2009 
(43)).  
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Methodological quality 
 
Each study was reviewed and a consensus meeting was convened to ensure quality assurance. The 
most prominent pitfall identified was a lack of generalizability of the study results to whole populations, 
as most studies were restricted to certain geographical areas, countries, or provinces/ regions. There 
were two studies in which limitations were not mentioned by the authors (48, 49). In addition, three of 
the studies had a response rate less than 50% (29, 50, 51), which can be a limitation to the 
generalization of the results of these studies. In some of the studies, participants were from different 
specialties and treating different infectious diseases (51-54), while other studies were specific and a 
certain disease condition such as paediatric common colds (49), URTIs (29, 35, 50, 55, 56), and 
surgical site infections (57). In some of the studies, the authors stated that the respondents may be 
triggered to the topic and gave socially desirable answers [23]. Four of the included studies (56, 58-
60) incorporated qualitative methodology and although they addressed the topic with an in-depth 
exploration, their findings are not possible to be generalized.   
 
x Characteristics of selected studies 
The study setting was ambulatory care in eight studies (29, 35, 48, 49, 56, 60-62), hospital setting in 
seven studies (51, 52, 54, 57, 63, 64) and both primary and hospital care in four studies (39, 50, 55, 
58). Sixteen studies focused solely on physicians, while three studies included pharmacists, patients 
or the general public. However, for the studies that also reported results related to other groups, e.g. 
pharmacists and/or patients, only their results related to physicians are reported in this review.  
 
In these studies, the response rates varied widely from 33% to 87% (Table 1). The lowest response 
rate (33%) was reported in a Spanish study. By using telephone call reminder and follow up, Wester 
et al and Mohan et al achieved higher response rates, 87% and 84.4% respectively (35, 53).  
 
With respect to the disease/clinical condition, ambulatory care infections including URTIs, diarrhoea, 
the common cold and sore throats were the subject of 11 studies (29, 35, 39, 48-50, 55, 56, 58, 60, 
61, 64). Other studies targeted infections in various specialties in hospital settings. As shown in Table 
1, it is important to note that the study variables and objectives varied between the different studies. 
Some of them focused on knowledge and other studies focused on attitudes or beliefs or prescribing 
practices.  
 
Main findings 
 
The findings will be divided into five sections starting with the knowledge of physicians regarding the 
prescribing of antibiotics 
 
x Knowledge of physicians regarding the prescribing of antibiotics  
 
Six studies evaluated the knowledge of physicians towards antibiotic use and resistance (39, 51, 53, 
54, 64, 65).  
 
7KUHHVWXGLHVIURPWKH8QLWHG6WDWHV868.DQG3HUXDVVHVVHGGRFWRU¶VNQRZOHGJHUHJDUGLQJ
antibiotic use in upper respiratory tract infections (URTIs) (29, 61, 64).  In the US study, 99.5% of the 
surveyed residents thought they had at least average knowledge about the treatment of URTIs (29). 
Most participants agreed that there was no need to start antibiotics in mild cases of URTIs in the US 
(81%) and Peru (76%), but a considerable percentage thought that more symptomatic events, such 
as patients with purulent nasal discharge, would need an antibiotic (29, 64). Physicians in UK 
acknowledged that antibiotics were prescribed too often for URTIs in primary care settings, although 
they were aware of the evidence for the limited effect of antibiotic treatment in this situation (61). 
Moreover in these studies, physicians commented on reducing antibiotic usage in URTIs and the 
relationship with the treatment outcome (49, 61, 64).  
 
Cho et al in Korea conducted a study on the prescribing of antibiotics in children with a common cold. 
The study showed that physicians in this study agreed that they could reduce by more than a quarter 
their antibiotic use withRXWMHRSDUGL]LQJWKHLUSDWLHQWV¶WUHDWPHQWRXWFRPH1HYHUWKHOHVVRI
physicians believed antibiotics could reduce the occurrence of complications. In other studies, 
physicians in United Kingdom (61) and Peru (64) thought that prescribing narrow spectrum antibiotics, 
and prescribing them occasionally, could do little or no harm in terms of the development of antibiotic 
resistance. Chamany et al (50) in the US found that majority of the physicians (92%) agreed that 
fewer antibiotics will reduce the risk of antibiotic resistance. However they were concerned about 
SDWLHQWV¶GLVVDWLVIDFWLRQLIDQWLELRWLFVZHUHQRWprescribed. Consequently, 64% of them thought it was 
necessary, and would eventually prescribe antibiotics to their patients with upper respiratory tract 
infections. Similar results were reported by physicians in Europe where they felt that antibiotic 
prescribing should be minimized to prevent escalating of antibiotic resistance (56). 
 
x Attitudes and confidence level in making antibiotic decisions 
 
Five studies assessed confidence levels among the physicians in their prescribing of antibiotics. 
There was a strong consistency among physicians with respect to their confidence level in making 
decisions on antibiotic prescribing. Some doctors especially junior doctors or those in their internship 
always discussed URTI care with senior physicians (59%-98%), yet only 2.8% to 5.4% of them did not 
feel confident making decisions regarding treatment (29, 39, 65). Some of the physicians in Peru and 
DR Congo (31% and 54.5% respectively) agreed it is difficult to select the correct antibiotics for their 
patients (39, 64). However in one study by Srinivasan et al, those who reported they were very 
confident in their antimicrobial use did not appear to have a better knowledge regarding antibiotics 
than those who were not confident (54). Despite their confidence, physicians find it difficult to select 
correct antibiotics for their patients. As a result, physicians do consult a colleague when prescribing 
antibiotics (39).  However, this is less likely in the private sector where physicians prescribe in 
isolation 
 
82% of respondents in a US study opted to use a diagnostic test (rapid antigen detection test or 
culture) to help decision making in the management of URTIs (29). However in two studies conducted 
in LMICs (35, 52), doctors did not favour using laboratory services due to a lack of, or limited, 
diagnostic facilities coupled with a delay in receiving the test results; alternatively, the belief that it is 
not necessary. In addition, in countries where payments for healthcare services are by the patient, i.e. 
out-of-pocket payments, physicians did not want to burden their patients with laboratory fees where 
they could not afford these (60). 
 
x Awareness towards antibiotic resistance 
 
Most of the studies reported that physicians had a general idea about the problem of resistance and 
its consequences. However, the majority of the studies reported that physicians had a low level of 
knowledge regarding the prevalence of antibiotic resistance rates in their local settings (39, 51, 53, 
64, 65). For example, Pulcini et al. showed that only 16% of young doctors in a French hospital knew 
the actual proportion of community acquired-Escherichia coli resistant to fluoroquinolones (65). 
Similarly, only 10% respondents in DR Congo knew about Klebsiella spp. resistant to ceftriaxone (39). 
However, physicians who specialized in infectious disease (ID) estimated antibiotic resistance rate 
more accurately compared to physicians in general medicine and other non-ID subspecialists (53). In 
two of the studies, senior residents in Spain and junior doctors in United Kingdom knew more about 
the prevalence of MRSA compared to other physicians in their practicing centres (51, 65). In these 
studies, years of practice and past training experience did not influence SK\VLFLDQV¶ knowledge level.  
 
Physicians from three studies (48, 49, 61) agreed that antibiotic overuse in outpatients contributed to 
the emergence of resistance. Contrary to this, participants from three studies considered antibiotic 
use in secondary healthcare or hospital setting as the main contributor to the existence of resistance 
(56, 58, 59). Encouragingly, over 90% of physicians in two studies in the US agreed that there would 
be a reduced risk of antibiotic resistance infections if fewer and better use of antibiotics were 
practiced (50, 54).  
 
x Source of information and familiarity with guidelines 
 
Several studies evaluated the main sources of information used by physicians regarding antibiotics. 
The majority of the physicians in the studies were familiar with guidelines related to antibiotics, but still 
some were not using them. For example in Sudan, only 32.6% of physicians referred to Sudan 
National Formulary (SNF)or the British National Formulary (BNF), while the remainder did not use any 
reference source for their decision making (57). Physicians in Peru referred to the Sanford Guide on 
Antimicrobial Therapy for information regarding antibiotics, and considered it as a very useful source 
(64). Similarly, 66.3% of physicians in DR Congo referred to guidelines when making treatment 
choices. However, the WHO Guidelines appeared to be the least popular as an information source as 
only 26.6% of them stated they used them as a reference (39). Physicians in Spain appreciated the 
recommendations contained in clinical guidelines; however, preferred these to be adapted to the local 
situation (59).  
 
Pocket-based antibiotic guidelines were rated as the most useful source of information. For example, 
the majority (98%) of the respondents in a US study and 50% in two public hospitals in Peru used 
µThe Sanford Guide¶, a pocket-sized guideline (39, 54). Physicians in India wanted antibiotic 
guidelines to be provided in all community hospitals to assist them in their appropriate use (60). 
However, 36% of respondents in Peruvian hospitals said the national guideline was not useful, while 
25% said they were not familiar with it (64). 
 
In several studies, pharmaceutical companies were regarded as one of the major influences of 
antibiotic prescribing. For example, 20% of the physicians in US reported that their interaction with 
pharmaceutical representatives influenced their own antimicrobial selections (54). Similar result were 
found in a Spanish study by Vazque-Lago et al where physicians attributed a very clear influence from 
pharmaceutical promotion and advertising when it came to choosing antibiotics (59). However in 
Trinidad, general practitioners did not feel pressured by pharmaceutical companies promotional 
efforts to prescribe antibiotics to their patients (35). Other than clinical guidelines and information 
provided by the pharmaceutical companies, physicians also believed in educational courses and 
internet-based information to assist with future prescribing of antibiotics (39, 64).  
 
x Practice and factors influencing prescribing behaviour 
 
Several factors were reported in the literature that could influence prescribing behaviour. 73% of 
physicians in Korea reported that parents expected an antibiotic prescription during the consultation. 
Consequently, 40% of them prescribed antibiotics even if they felt these were unnecessary (49). 
Similar results have been found in DR Congo where 62% of physicians perceived patients pressure 
being a contributing factor to the overuse of antibiotics in the community (39). However in South 
$IULFDWKHSUHVFULEHUVUHSRUWHGWKDWWKH\ZHUHOHDVWLQIOXHQFHGE\SDWLHQWV¶UHTXHVWRUH[SHFWDWLRQV
(52).  
 
Among other reported reasons for prescribing antibiotics were the severity of illness and duration of 
infections (35), to avoid secondary bacterial infections (35, 55), or because of uncertainty between 
bacterial or viral infections (55)IROORZLQJSDWLHQWV¶UHTuest or perceived request (49, 50, 60, 61, 66), 
and afraid of losing patients (49, 60). More than half of European primary care paediatricians (65.1%) 
reported of using delayed antibiotic prescribing  in management of URTIs, a method which is 
recommended by the National Institute for Health and Clinical Excellence (NICE) (55). 
 
Other factors influencing the prescribing of antibiotics, including economic factors as well as the 
availability and supply of antibiotics, were not typically mentioned in the papers incorporated into this 
review. However, it is acknowledged they do influence prescribing (19, 21, 25). 
 
Discussion 
 
The same sections will be discussed to provide future guidance 
 
x Knowledge among physicians regarding antibiotics and antibiotic resistance  
 
This systematic review showed that physicians had a general idea about antibiotic resistance as a 
clinical problem, but they were underestimating its prevalence. Knowledge of antibiotic resistance 
rates was not related to the level of experience among the practitioners. In this aspect, physicians 
have an overview of resistance as a problem, showing a high level of awareness that this may 
jeopardize future patient care. However, few perceived that antibiotic resistance was an important 
problem in their own clinical practice, suggesting that many physicians see the risk of antibiotic 
resistance as more theoretical than actual, possibly weakening the motivation for behaviour change 
(53). Although many doctors agreed that reducing antibiotics will reduce the risk of antibiotic 
resistance, there is still there a high proportion reporting they would prescribe antibiotics for conditions 
for which antibiotics are not usually indicated. This indicates that several external factors may also 
influence their prescribing. Identified factors included DYRLGLQJSDWLHQWV¶GLVVDWLVIDFWLRQDQG
sometimes their own belief that the antibiotic would be necessary (50). Also, they may believe that 
they are more effective as physicians when they prescribe medications to treat their patients, even 
though this may be unnecessary. However, this is speculation at this stage and needs further 
research. In any event,  this underscores the importance of educational sessions including active 
drugs and therapeutic committees (DTCs) and dissemination of guidelines as well as the availability 
of local resistance data to improve future antibiotic prescribing (20, 24, 25, 51, 67).  
 
Regarding their practice, physicians believed that wide and easy access to up-to-date information 
would allow them to make more informed decisions about antibiotic prescribing, including selecting 
narrow-spectrum antibiotics that are most likely to be effective (56). However, the low average score 
of knowledge regarding antibiotic use and resistance suggests that antimicrobial education has been 
suboptimal (54). Reduced knowledge has made physicians, as well as the patients, believe that 
antibiotics are standard treatment for a number of conditions even if this may not be the case. It is 
also believed that physician personal experience with antibiotic resistance will increase their 
awareness about the importance of harmful effects caused by antibiotic resistance (53). Knowledge 
and appropriate antibiotic use may also improve as physicians advance through education, training 
and clinical practice. Consequently,  improving antibiotic prescribing through training physicians in 
continuing medical education programmes, and issuing clinical guidelines for their appropriate use 
based on local microbiological data, are important strategies(60).  
 
The review by Huttner et al showed that a number of interventions can be used to educate physicians 
regarding the prescribing of antibiotics. These include academic detailing, audit and feedback of 
prescribing behaviour as well as the distribution of guidelines (68, 69). Other authors have shown that 
the implementation of guidelines and subsequent improvement in prescribing is enhanced by keeping 
them up-to-date, involving all key stakeholders in their compilation, as well as incorporating multiple 
components in their implementation (26, 70). This includes  active dissemination strategies coupled 
with monitoring and feedback of prescribing patterns  as well as keeping guidelines simple and limited 
in number (69-77). Trust in those developing the guidance is also important given the appreciable 
potential for bias (72, 73, 78). Multiple interventions can be divided into managerial approaches 
alongside educational interventions (20).  Managerial interventions include computerized decision 
support systems, prescribing indicators, community case management programmes, formulary 
restrictions and prior authorisations (19, 20, 25, 79). The added influence of multiple interventions 
alongside educational activities to favourably influence physician prescribing has also been shown in 
other disease areas with interventions including indicators, financial incentives to all key stakeholder 
groups and prescribing restrictions (80-83). Barriers to change not only relate to physicians but other 
parties including patients, health care systems, available resources, leadership and the current 
political environment. Consequently, strategies need to be tailored and targeted at different levels to 
improve the future use of medicines including antibiotics (70).  
 
x Attitudes and confidence level in making antibiotic decisions 
 
Many studies in the literature reported that junior physicians or physicians in training were less 
confident about antibiotic prescribing compared to attending physicians with more years of clinical 
experience. Low knowledge of antibiotics may account for less confidence among the physicians in 
their ability to use antibiotics optimally (54). Physicians without a recent formal teaching or training on 
antimicrobials were less knowledgeable compared to those with exposure to formal teaching, 
suggesting that when education does occur it is effective (54).  
 
Furthermore, physicians in the first year of practice chose antibiotics more frequently for viral URTIs 
than did those in longer period of practice (29). This suggests it is important that the rational use of 
antibiotics and antibiotic resistance are adequately covered and emphasized during medical 
education. Junior doctors should also be a target group for future interventions to improve antibiotic 
prescribing.  
 
x Practice and factors influencing prescribing behaviour 
 
Patient demand and perceived need for a quick relief of their symptoms does appear to promote 
inappropriate antibiotic use. Attempting though WRFKDQJHSDWLHQW¶VEHOLHIVDQGH[SHFWDWLRQVGXULQJWKH
consultation is often perceived as time-consuming and unrewarding (61). Physicians, especially those 
at outpatient settings, do respond to the demands of patients by prescribing antibiotics rather than 
providing explanations why antibiotics are not needed. This though can raise concerns that some 
physicians practicHµWKURZLQJDQWLELRWLFVDWHYHU\WKLQJ¶WDNLQJWKHHDV\ZD\RXWUDWKHUWKDQVSHQGLQJ
some time discussing potential treatments including why not prescribing antibiotics with their patients 
(50). However, LQWRGD\¶VKHDOWKFDUHV\VWHPZKHUHSK\VLFLDQVin many countries have only a few 
minutes to fully evaluate the patient, make a diagnosis and prescribe a treatment, and given the 
increasingly litigious nDWXUHRIVRFLHW\WKH\IUHTXHQWO\¿QGWKHPVHOYHVXQGHUWUHPHQGRXVSUHVVXUHWR
prescribe an antibiotic even when this may not be appropriate (4).  
 
These findings highlight the need for training for physicians to educate patients in the rational use of 
antibiotics, especially in outpatient settings, in order to improve their practice. Educational 
interventions and campaigns to improve antibiotic prescribing must also target patients as they do 
influence prescribing decision. Patient campaigns could include education by healthcare 
professionals, distribution of leaflets and posters in public places, e.g. shopping malls, bus stations, 
and clinics as well as mass media including newspaper advertisements and possibly the TV, building 
on examples in the literature that have resulted in  a more judicial use of antibiotics (68).  
 
A number of campaigns have been successfully undertaken across countries to improve antibiotic 
use. This includes Australia, Chile, Europe and Korea. A summary of the programmes and their 
impact are contained in Table 2.  
 
Table 2 ± Summary details of programmes to influence the subsequent use of antibiotics and their 
impact 
 
 
Country Summary details and impact 
Australia (20) x The National Prescribing Service (NPS) conducted an antibiotic promotion 
programme to promote the quality use of antibiotics 
x The programme targeted general practitioners (GPs), pharmacists and 
consumers, with activities including academic retailing or clinical audits, 
prescribing feedback (for GPs), newsletters and promotional materials to 
consumers via radio, TV, and local newsletters. In addition, books and 
resources were distributed to GPs and community pharmacies 
x The programme has resulted in a major reduction in antibiotic use, e.g. 
reducing the number of antibiotic prescriptions for URTIs from 80 per 1000 
consultations in 1996 to 50 per 1000 consultations in 2007 
Chile (20) x A new regulation in 2000 prohibiting the dispensing of antibiotics without 
prescription was associated with a reduction in overall sales of antibiotics in 
the private sector 
x Utilisation declined from 0.34 DDD/1000 inhabitant-days (UD$37,603,688) in 
1996 to 0.25 DDD/1000 inhabitant-days (UD$32,141,856) in 2000  
Europe ± France 
(42) 
x /DXQFKLQJRIWKHPXOWLIDFHWHGQDWLRQDOSURJUDPPHµ.HHS$QWLELRWLFV:RUNLQJ¶
targeting all key stakeholders in 2001 
x 7KLVSURJUDPPHZDVFRXSOHGZLWKWKHSXEOLFVHUYLFHFDPSDLJQµ$QWLELRWLFV
are not automatiF¶HYHU\ZLQWHUVLQFH 
x Compared to the pre-intervention period (2000±2002), the total number of 
antibiotic prescriptions per 100 inhabitants, adjusted for the frequency of flu-
like symptoms during the winter season, decreased by 26.5% in the 2003-
2007 period. The greatest reduction in antibiotic use (-36%) was seen among 
children  
Europe ± Italy 
(84) 
x A community-based educational intervention was instigated to improve 
antibiotic prescribing in the outpatient setting 
x This included posters, brochures, and advertisements in the local media 
targeting the community coupled with a newsletter on antibiotic resistance 
targeting pharmacists and physicians 
x The multifaceted programme subsequently significantly improved antibiotic 
prescribing  
Europe ± x Multifaceted interventions were conducted from 1999/ 2000 onwards in 
Slovenia (85) Slovenia 
x This involved all key stakeholder groups including the Ministry of Health, 
Health Insurance, physician groups and patients 
x The multifaceted programmes reversed a 24% increase in antibiotic 
consumption during the 1990s to a 31% reduction by 2012 compared with 
the late 1990s. Expenditure on antibiotics was decreased by 53%  
Europe ± Sweden 
(86, 87)  
x The multifaceted Swedish Strategic Programme for the Rational Use of 
Antimicrobial Agents and Surveillance of Resistance (STRAMA) ² had a 
major contribution to reducing antibiotic use in Sweden 
x Over ten years (1995-2004), antibiotic use for outpatients decreased from 
15.7 to 12.6 DDDs per 1000 inhabitants per day, and from 536 to 410 
prescriptions per 1000 inhabitants per year  
Korea (20, 34) x A national policy was introduced in 2000 prohibiting the dispensing by 
general practitioners of medicines including antibiotics 
x This was associated with a reduction in antibiotic use from 80.3 to 72.8% for 
viral illness episodes and from 91.6 to 89.7% for bacterial illness episodes 
 
In 2008, the Centre for Clinical Practice at National Institute for Health and Clinical Excellence (NICE) 
developed a guideline for antibiotic prescribing in upper respiratory tract infections for adults and 
children in ambulatory care. They emphasized delayed antibiotic prescribing as a safe method of 
implementing alternatives to immediate antibiotic prescribing for acute uncomplicated URTIs to 
promote their rational use (88). In the US, pharmacists are being encouraged to become a part of 
antimicrobial stewardships in hospitals to improve subsequent antibiotic use with future implications 
for the community (89).  
 
In line with implementing suggested prescribing approaches, communication skills and certainty of the 
diagnosis ranked among the highest indirect factors influencing antibiotic prescription (90). Physicians 
may feel that using prescriptions to bring a difficult consultation to a conclusion was the only way to 
get through a busy clinical schedule (91)7KLVIDFWRULVDOVRUHODWHGWRSDWLHQWV¶H[SHFWDWLRQVZKHUH
some studies showed that improvement in communication between physician and patients can 
UHGXFHSDWLHQWV¶expectation to antibiotic treatment (92-94).  
 
In Malaysia, activities were undertaken by the Ministry of Health (MOH) WRLPSURYHSDWLHQWV¶
knowledge of their medicines as well as improve antibiotic prescribing. General initiatives included 
µ.QRZ<RXU0HGLFLQH¶FDPSDLJQLQitiated in 2010, based on the 5Rs, i.e. Right patient, Right 
medicine, Right dose, Right route and Right time. This involved communication campaigns in 
hospitals, media, and the community including supermarkets, religious places, schools and 
community halls. Initiatives to improve the prescribing of antibiotics included the establishment of the 
Infection Control and National Antibiotic Committee in Malaysia in 2000, with monitoring of antibiotic 
utilization patterns ongoing since 2005 (95). This has been conducted under the annual National 
Medicines Use Survey. Future activities include ascertaining point prevalence data where patient level 
data will be collected and fed back to physicians to improve future antibiotic prescribing as well as 
campaigns with patients. 
 
x Source of information and familiarity with guidelines 
 
In the various studies, there were several information sources available to physicians. These include 
colleagues, pharmaceutical company representatives, guidelines, electronic data sources, and 
medical journals. Pharmaceutical companies appear to exert appreciable influence on antibiotic 
usage. This was demonstrated by Sondergaard et al, who showed that visits from pharmaceutical 
representatLYHVKDGDVLJQLILFDQWLPSDFWRISK\VLFLDQV¶VXEVHTXHQWSUHVFULELQJ (96). Similar result has 
been reported in by McGettigan et al, who found that information on new medicines prescribed had 
come from pharmaceutical representatives in 42% of cases (97). This is not surprising, as 
pharmaceutical companies engage in an appreciable number of activities to enhance the funding and 
utilisation of their medicines (98-101). However, some physicians reported that they prescribed 
promoted medicines within a certain time period and when the promotion from pharmaceutical 
companies stopped, physicians claimed they would also stop prescribing the medicines (59). 
 
Typically, information provided by pharmaceutical companies ranked among highest choice of 
references among physicians. This highlights the prominent role of pharmaceutical industry as a key 
source of information about medicines, especially in low and middle income countries (17, 102, 103). 
This is of concern as drug promotion, especially in developing countries, may not always be evidence-
based adversely impacting on future care (17, 104, 105). Undue pressure on healthcare providers by 
pharmaceutical companies may also increase inappropriate use (43,76). Consequently, it is important 
to counteract this influence if this adversely affects the rational use of medicines. Several countries 
have taken steps in this regard (83, 106-108). In Croatia, pharmaceutical companies are required to 
report all their promotional expenses as well as financial remuneration to physicians for prescribing. 
Contact between pharmaceutical company representatives and physicians is also limited, enforced 
through financial penalties (83). In South Korea, by law pharmaceutical companies must not pay for 
physicians to participate in conferences, leading to fines for abuse (106). In the US, pharmaceutical 
companies are now required to report their gifts and payments to physicians (108). These countries 
provide examples on how relationships between pharmaceutical companies and healthcare 
professionals can be addressed to reduce their influence on future prescribing, reducing potential 
concerns (109).      
 
Pocket-sized treatment guidelines seem to be most popular as an information source, suggesting that 
small and handy types of references are more preferred and more accessible.  This is important as 
poor adherence to guidelines increases medication risks and decreases antibiotic benefit through 
wrong choices and dosing by physicians (58). 
 
We are aware that eleven of the included studies were conducted in developed countries (29, 49-51, 
53-56, 59, 63, 110), while eight studies were conducted in developing countries including Bangladesh, 
DR Congo, India, Lesotho, Peru, Sudan and Trinidad and Tobago (35, 39, 48, 52, 57, 58, 60, 64). 
There are appreciable differences in healthcare delivery between developed and LMICs, with limited 
information and lack of resources creating barriers to accessing and providing adequate healthcare in 
developing countries. This does create differences. Having said this, physician knowledge of 
resistance appeared adequate across studied countries with most studies reporting that physicians 
had a general idea about the problem of resistance and its consequences. However, this did not 
always translate into appropriate prescribing of antibiotics. This may be due to patient pressure to 
prescribe antibiotics among both developed and developing (LMIC) countries.  Differences between 
countries included the fact that in developed countries, internet based information served as a 
common resource of information. This is in contrast with the developing (LMIC) countries where 
internet resources are used by only some physicians. Limited access to internet connection and other 
electronic facilities has made information from the internet more difficult to access compared to other 
available resources (39). This though is likely to change in the future. Knowledge and perceptions 
among physicians in LMICs may also be different. They agree that antibiotic prescriptions can be 
reduced; however, they believed that prescribing narrow spectrum of antibiotics occasionally are 
safe(64). Choosing correct antibiotics are often difficult in LMICs due to a lack of local guidelines and 
limited access to up-to-date international guidelines; therefore the majority of physicians will consult a 
colleague when doing so (39, 64). Physicians in LMIC also believe laboratory tests may not always be 
necessary, due in part to limited of diagnostic facilities, delay in receiving the test results, and many 
patients unable to afford laboratory fees (60). Physicians in LMIC countries may also feel pressured 
by pharmaceutical company promotions; however, this is not universal  (21, 35, 98). Other factors 
influencing antibiotic utilization in LMIC countries relate to the health system, i.e. unavailability of the 
recommended antibiotic (24), oversupply of antibiotics and near-expiry antibiotics in some primary 
healthcare centers (21), as well as economic benefits from prescribing certain antibiotics over 
others(21, 24, 33) .  
 
We are also aware that we included different physician specialties. This is because of the very limited 
number of studies that only concentrate on one physician group.  For example, Fakih et al included 
residents from different specialties, i.e. internal medicine, family medicine, emergency medicine and 
paediatrics (29), Grossman et al and Cho et al included primary care/ family physicians and 
paediatricians (49, 55), Pulcini et al included physicians from different medical and surgical specialties 
(63), and Srinisavan et al studied physicians from different medical specialties including general 
medicine, emergency medicine, Obstetrics/ gynaecology, surgery and neurology (54).   
 
Other limitations include the fact that the literature search was carried out based on electronic 
databases WRZKLFKWKHDXWKRUV¶XQLYHUVLW\OLEUDU\VXEVFULEHG$VD result, it is possible that some 
studies might not have been retrieved. In addition, papers that were published in languages other 
than English were excluded from the review. Moreover, the review focused on the recent literature, 
i.e., from 1990 and onwards. However, we believe this is justified because older studies might not be 
relevant to current practices. Nevertheless, overall we believe the findings of this systematic review 
are robust and can provide excellent guidance for the future to promote the rational use of antibiotics.   
 
Conclusion 
 
It is evident from the various studies that inappropriate prescribing and knowledge of antibiotics is a 
concern among physicians in general and young physicians in particular, with physicians willing to 
prescribe antibiotics even for viral illnesses. Several factors appear to influence prescribing behavior. 
These include demands from patients, pharmaceutical company marketing activities, limited up-to-
date information sources and physicians afraid of losing their patients. Inappropriate prescribing of 
antibiotics when it occurs also appears to be related to inadequate knowledge or training on the 
appropriate prescribing of antibiotics. It was encouraging to see that  physicians were interested in 
learning more and improving their prescribing practice to address this. The majority of the physicians 
in the studies also wanted more feedback on their antibiotic prescribing decisions. Issues of supply, 
healthcare infrastructure as well as financial incentives can also affect subsequent antibiotic 
prescribing and utilization especially in LMIC countries.  
 
This provides guidance for the future given the projected mortality and financial implications if the 
increase in inappropriate antibiotic prescribing and AMR is unchecked. Typically, multifaceted and 
multilevel interventions strategies that target all key stakeholders, including physicians and patients, 
are needed to improve the rational use of antibiotics thereby helping reduce resistance development. 
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Key points 
 
x 8QGHUVWDQGLQJSK\VLFLDQV¶NQRZOHGJHUHJDUGLQJDQWLELRWLFVKRw this knowledge is acquired and 
maintained, as well as factors influencing the prescribing of antibiotics is key to introducing future 
strategies to enhance the rational use of antibiotics. As a result, help reduce future resistance 
development 
x A systematic review was undertaken to assess current knowledge to provide future direction. This 
eventually involved 19 papers from 1633 titles and abstracts once only pertinent papers were 
included. The studies were across healthcare sectors and involved both developed and 
developing countries 
x The main findings showed that some physicians still have inadequate knowledge and 
misconceptions about antibiotic prescribing. In addition, whilst aware that antibiotics are of limited 
benefit or unnecessary for some conditions they were still prescribed 
x Influencers of physician prescribing included SDWLHQWV¶UHTXHVWVDQGH[SHFWDWLRQVVHYHULW\DQG
duration of infections, belief  that antibiotics can prevent secondary bacterial infections, 
uncertainty between bacterial or viral infections, potential losing of patients if antibiotics are not 
prescribed, influence of pharmaceutical companies and limited access to information sources on 
antibiotic prescribing 
x Pocket-size guidelines were seen as the most important source of information on antibiotic 
prescribing. This along with future training and feedback will help improve future antibiotic 
prescribing 
x Educating patients is also important to improve the future rational use of antibiotics 
 
 
References 
 
1. HM Government. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. 
Available at URL: http://www.jpiamr.eu/wp-content/uploads/2014/12/AMR-Review-Paper-Tackling-a-crisis-for-the-
health-and-wealth-of-nations_1-2.pdf 
2. Bosch F, Rosich L. The Contributions of Paul Ehrlich to Pharmacology: A Tribute on the Occasion of the 
Centenary of His Nobel Prize. Pharmacology. 2008;82(3):171-9. 
3. Alharbi SA, Wainwright M, Alahmadi TA, Salleeh HB, Faden AA, Chinnathambi A. What if Fleming had 
not discovered penicillin? Saudi journal of biological sciences. 2014;21(4):289-93. 
4. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Archives of medical research. 
2005;36(6):697-705. 
5. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology 
Reviews. 2010;74(3):417-33. 
6. Almeman AA, Ibrahim MIM, Rasool S. Cost Analysis of Medications Used in Upper Respiratory Tract 
Infections and Prescribing Patterns in University Sans Malaysia, Penang, Malaysia. Tropical Journal of 
Pharmaceutical Research. 2014;13(4):621-6. 
7. Kho B, Ong C, Tan F, Wee C. Antibiotic prescribing for upper respiratory tract infections in sarawak 
district hospitals. The Medical journal of Malaysia. 2013;68(2):136-40. 
8. Larsson M, Kronvall G, Chuc N, Karlsson I, Lager F, Hanh H, et al. Antibiotic medication and bacterial 
resistance to antibiotics: a survey of children in a Vietnamese community. Tropical Medicine & International 
Health. 2000;5(10):711-21. 
9. Nash DR, Harman J, Wald ER, Kelleher KJ. Antibiotic prescribing by primary care physicians for 
children with upper respiratory tract infections. Archives of pediatrics & adolescent medicine. 2002;156(11):1114-
9. 
10. Barnett ML, Linder JA. Antibiotic Prescribing for Adults With Acute Bronchitis in the United States, 1996-
2010. JAMA. 2014;311(19):2020-2. 
11. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on 
antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096. 
12. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and 
association with resistance: a cross-national database study. The Lancet. 2005;365(9459):579-87. 
13. Kesselheim AS, Outterson K. Fighting antibiotic resistance: marrying new financial incentives to meeting 
public health goals. Health Affairs. 2010;29(9):1689-96. 
14. Conly J. Controlling antibiotic resistance by quelling the epidemic of overuse and misuse of antibiotics. 
Canadian family physician Medecin de famille canadien. 1998;44:1769-73, 80-4. 
15. World Health Organisation. WHO global strategy for containment of antimicrobial resistance 2001. 
Available at URL: http://www.who.int/csr/resources/publications/drugresist/en/EGlobal_Strat.pdf 
16. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on 
antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340. 
17. Van Nguyen K, Do NTT, Chandna A, Nguyen TV, Van Pham C, Doan PM, et al. Antibiotic use and 
resistance in emerging economies: a situation analysis for Viet Nam. BMC public health. 2013;13(1):1158. 
18. Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ-British 
Medical Journal. 2012;344(3):e1567. 
19. Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D. Prescribing for acute 
childhood infections in developing and transitional countries, 1990-2009. Paediatrics and international child 
health. 2015;35(1):5-13. 
20. Holloway KA. Combating inappropriate use of medicines. Expert review of clinical pharmacology. 
2011;4(3):335-48. 
21. Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to 
prescribe antibiotics in Delhi India. Family practice. 2010;27(6):684-90. 
22. Holloway K, Mathai E, Gray A. Surveillance of antimicrobial resistance in resource-constrained settings - 
experience from five pilot projects. Tropical medicine & international health : TM & IH. 2011;16(3):368-74. 
23. Holloway K, Mathai E, Gray A. Surveillance of community antimicrobial use in resource-constrained 
settings--experience from five pilot projects. Tropical medicine & international health : TM & IH. 2011;16(2):152-
61. 
24. Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on 
determinants. Social science & medicine (1982). 2003;57(4):733-44. 
25. Holloway KA, Henry D. WHO essential medicines policies and use in developing and transitional 
countries: an analysis of reported policy implementation and medicines use surveys. PLoS medicine. 
2014;11(9):e1001724. 
26. Holloway KA, Ivanovska V, Wagner AK, Vialle-Valentin C, Ross-Degnan D. Have we improved use of 
medicines in developing and transitional countries and do we know how to? Two decades of evidence. Tropical 
medicine & international health : TM & IH. 2013;18(6):656-64. 
27. Earnshaw S, Mendez A, Monnet DL, Hicks L, Cruickshank M, Weekes L, et al. Global collaboration to 
encourage prudent antibiotic use. The Lancet infectious diseases. 2013;13(12):1003-4. 
28. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Social 
science & medicine. 1989;28(6):577-82. 
29. Fakih MG, Hilu RC, Savoy-Moore RT, Saravolatz LD. Do resident physicians use antibiotics 
appropriately in treating upper respiratory infections? A survey of 11 programs. Clinical infectious diseases. 
2003;37(6):853-6. 
30. Hassali MA, Kamil T, Faridah AMY, Alrasheedy AA, Yussoff ZM, Saleem F, AL-Tamimi SK, Wong ZY, 
$OMDGKH\+*RGPDQ%*HQHUDOSUDFWLWLRQHUV¶NQRZOHGJHDWWLWXGHDQGSUHVFULELQJRIDQWLELRWLcs for upper 
respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Review of Anti Infective 
Therapy Early online, 1±10 2015. 
31. Riaz H, Godman B, Hussain S, Malik F, Mahmood S, Shami A,  Bashir S. Prescribing of 
bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. Journal of 
Pharmaceutical Health Services Research - Accepted for publication. 2015. 
32. Trap B, Hansen EH. Treatment of upper respiratory tract infections--a comparative study of dispensing 
and non-dispensing doctors. Journal of clinical pharmacy and therapeutics. 2002;27(4):289-98. 
33. Li Y, Xu J, Wang F, Wang B, Liu L, Hou W, et al. Overprescribing in China, driven by financial 
incentives, results in very high use of antibiotics, injections, and corticosteroids. Health affairs (Project Hope). 
2012;31(5):1075-82. 
34. Park S, Soumerai SB, Adams AS, Finkelstein JA, Jang S, Ross-Degnan D. Antibiotic use following a 
Korean national policy to prohibit medication dispensing by physicians. Health policy and planning. 
2005;20(5):302-9. 
35. Mohan S, Dharamraj K, Dindial R, Mathur D, Parmasad V, Ramdhanie J, et al. Physician behaviour for 
antimicrobial prescribing for paediatric upper respiratory tract infections: a survey in general practice in Trinidad, 
West Indies. Annals of Clinical Microbiology and Antimicrobials. 2004;3(1):11. 
36. Mazzaglia G, Arcorac V, Cutroneo P, Inferrera S, Alecci U, Bonfiglio S, et al. Infectious diseases and 
antibiotic prescription in general practice. A surveillance study in Sicily. Malattie infettive in medicina generale e 
prescrizione di antibiotici Studio osservazionale in Sicilia. 1998;89(7-8):356-60. 
37. Chukwuani CM, Onifade M, Sumonu K. Survey of drug use practices and antibiotic prescribing pattern 
at a general hospital in Nigeria. Pharmacy World & Science. 2002;24(5):188-95. 
38. Rosman S, Le Vaillant M, Schellevis F, Clerc P, Verheij R, Pelletier-Fleury N. Prescribing patterns for 
upper respiratory tract infections in general practice in France and in the Netherlands. European Journal of Public 
Health. 2008;18(3):312-6. 
39. Thriemer K, Katuala Y, Batoko B, Alworonga J-P, Devlieger H, Van Geet C, et al. Antibiotic prescribing 
in DR Congo: a knowledge, attitude and practice survey among medical doctors and students. PloS one. 
2013;8(2):e55495. 
40. Piddock LJ. Antibiotic Action: helping deliver action plans and strategies. The Lancet infectious 
diseases. 2013;13(12):1009-11. 
41. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle P-Y, et al. Significant reduction of 
antibiotic use in the community after a nationwide campaign in France, 2002±2007. PLoS medicine. 
2009;6(6):e1000084. 
42. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY, et al. Significant reduction of 
antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS medicine. 
2009;6(6):e1000084. 
43. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. 
44. Godman B, Acurcio F, Guerra Júnior AA, Alvarez-Madrazo S , Faridah Aryani MY, Bishop I et al. 
Initiatives among Authorities to Improve the Quality and Efficiency of Prescribing and the Implications. Jn Pharma 
Care Health Sys. 2014;1(3):15. 
45. Wong ZY, Alrasheedy A, Salee, F, Yahaya A, Aljadhey H. . Malaysian generic pharmaceutical 
industries: perspective from healthcare stakeholders. Journal of Pharmaceutical Health Services Research. 
2014;5(4):193-203. 
46. Hassali MA, Wong ZY, Alrasheedy AA, Saleem F, Mohamad Yahaya AH, Aljadhey H. Perspectives of 
physicians practicing in low and middle income countries towards generic medicines: A narrative review. Health 
policy (Amsterdam, Netherlands). 2014. 
47. Al-Gedadi NA HM. Pharmacists' views on generic medicines: a review of the literature. Journal of 
Generic Medicines. 2008;5(3):209-18 
48. Sutradhar KB, Saha A, Huda NH, Uddin R. Irrational Use of Antibiotics and Antibiotic Resistance in 
Southern Rural Bangladesh: Perspectives from Both the Physicians and Patients. 
49. Cho H-J, Hong S-J, Park S. Knowledge and beliefs of primary care physicians, pharmacists, and 
parents on antibiotic use for the pediatric common cold. Social Science & Medicine. 2004;58(3):623-9. 
50. Chamany S, Schulkin J, Rose CE, Riley LE, Besser RE. Knowledge, attitudes, and reported practices 
among obstetrician-gynecologists in the USA regarding antibiotic prescribing for upper respiratory tract infections. 
Infectious diseases in obstetrics and gynecology. 2005;13(1):17-24. 
51. Navarro-San Francisco C, Del Toro MD, Cobo J, De Gea-García JH, Vanó-Galván S, Moreno-Ramos F, 
et al. Knowledge and perceptions of junior and senior Spanish resident doctors about antibiotic use and 
resistance: Results of a multicenter survey. Enfermedades Infecciosas y Microbiología Clínica. 2013;31(4):199-
204. 
52. Adorka M, Dikokole M, Mitonga KH, Allen K. Healthcare providers' attitudes and perceptions in infection 
diagnosis and antibiotic prescribing in public health institutions in Lesotho: a cross sectional survey. African 
Health Sciences. 2013;13(2):344-50. 
53. Wester CW, Durairaj L, Evans AT, Schwartz DN, Husain S, Martinez E. Antibiotic resistance - A survey 
of physician perceptions. Archives of Internal Medicine. 2002;162(19):2210-6. 
54. Srinivasan A, Song X, Richards A, Sinkowitz-Cochran R, Cardo D, Rand C. A survey of knowledge, 
attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and 
resistance. Archives of internal medicine. 2004;164(13):1451-6. 
55. Grossman Z, del Torso S, Hadjipanayis A, van Esso D, Drabik A, Sharland M. Antibiotic prescribing for 
XSSHUUHVSLUDWRU\LQIHFWLRQV(XURSHDQSULPDU\SDHGLDWULFLDQV¶NQRZOHGJHDWWLWXGHVDQGSUDFWLFH$FWD
Paediatrica. 2012;101(9):935-40. 
56. Wood F, Phillips C, Brookes-Howell L, Hood K, Verheij T, Coenen S, et al. Primary care clinicians' 
perceptions of antibiotic resistance: A multi-country qualitative interview study. Journal of Antimicrobial 
Chemotherapy. 2013;68(1):237-43. 
57. Zaki A, Kheder S. A survey of patterns, attitudes, and beliefs of house staff physicians concerning 
antibiotic use in Khartoum state hospitals. Elixir International Journal. 2012;44:7251-5. 
58. Chandy SJ, Mathai E, Thomas K, Faruqui AR, Holloway K, Lundborg CS. Antibiotic use and resistance: 
perceptions and ethical challenges among doctors, pharmacists and the public in Vellore, South India. Indian 
journal of medical ethics. 2012;10(1):20-7. 
59. Vazquez-Lago JM, Lopez-Vazquez P, López-Durán A, Taracido-Trunk M, Figueiras A. Attitudes of 
primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from 
Spain. Family practice. 2011:cmr084. 
60. Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K. Factors influencing primary care physicians to 
prescribe antibiotics in Delhi India. Family Practice. 2010;27(6):684-90. 
61. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: 
qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. Bmj. 
1998;317(7159):637-42. 
62. Vazquez-Lago JM, Lopez-Vazquez P, López-Durán A, Taracido-Trunk M, Figueiras A. Attitudes of 
primary care physicians to the prescribing of antibiotics and antimicrobial resistance: A qualitative study from 
Spain. Family Practice. 2012;29(3):352-60. 
63. Pulcini C, Naqvi A, Gardella F, Dellamonica P, Sotto A. Bacterial resistance and antibiotic prescriptions: 
Perceptions, attitudes and knowledge of a sample of French GPs. Résistance bactérienne et prescription 
antibiotique: perceptions, attitudes et connaissances d'un échantillon de médecins généralistes. 
2010;40(12):703-9. 
64. García C, Llamocca LP, García K, Jiménez A, Samalvides F, Gotuzzo E, et al. Knowledge, attitudes and 
practice survey about antimicrobial resistance and prescribing among physicians in a hospital setting in Lima, 
Peru. BMC Pharmacology and Toxicology. 2011;11(1):18. 
65. 3XOFLQL&:LOOLDPV)0ROLQDUL1'DYH\31DWKZDQL'-XQLRUGRFWRUV¶NQRZOHGJHDQGSHUFHSWLRQVRI
antibiotic resistance and prescribing: a survey in France and Scotland. Clinical Microbiology and Infection. 
2011;17(1):80-7. 
66. =RODO\0$+DQDIL0,)DFWRUV$IIHFWLQJ$QWLELRWLFV¶3UHVFULSWLRQLQ*HQHUDO3HGLDWULF&OLQLFV-RXUQDORI
Taibah University Medical Sciences. 2011;6(1):33-41. 
67. Holloway K, Green T. Drug and Therapeutics Committees: A practical guide. Available at URL: 
http://apps.who.int/medicinedocs/pdf/s4882e/s4882e.pdf; 
68. Huttner B, Goossens H, Verheij T, Harbarth S. Characteristics and outcomes of public campaigns aimed 
at improving the use of antibiotics in outpatients in high-income countries. The Lancet infectious diseases. 
2010;10(1):17-31. 
69. Sketris IS, Langille Ingram EM, Lummis HL. Strategic opportunities for effective optimal prescribing and 
medication management. The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie 
clinique. 2009;16(1):e103-25. 
70. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in 
patients' care. Lancet. 2003;362(9391):1225-30. 
71. Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier JP. Ongoing pharmaceutical 
reforms in France: implications for key stakeholder groups. Applied health economics and health policy. 
2010;8(1):7-24. 
72. Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M, et al. Interface 
management of pharmacotherapy. Joint hospital and primary care drug recommendations. European journal of 
clinical pharmacology. 2013;69 Suppl 1:73-8. 
73. Gustafsson LL, Wettermark B, Godman B, Andersen-Karlsson E, Bergman U, Hasselstrom J, et al. The 
'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of 
essential drugs in ambulatory care in Stockholm. Basic & clinical pharmacology & toxicology. 2011;108(4):224-
33. 
74. Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical 
guidelines for health care professionals: a systematic meta-review. BMC medical informatics and decision 
making. 2008;8:38. 
75. Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, et al. Barriers and facilitators to the 
implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC health 
services research. 2012;12:455. 
76. Grimshaw J, Campbell M, Eccles M, Steen N. Experimental and quasi-experimental designs for 
evaluating guideline implementation strategies. Family practice. 2000;17 Suppl 1:S11-6. 
77. Cantillon P, Jones R. Does continuing medical education in general practice make a difference? BMJ. 
1999;318(7193):1276-9. 
78. Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel 
members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ. 
2011;343:d5621. 
79. Parrino TA. Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-
2004. Pharmacotherapy. 2005;25(2):289-98. 
80. Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, et al. Comparing policies to enhance 
prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. 
Expert review of pharmacoeconomics & outcomes research. 2010;10(6):707-22. 
81. Martikainen JE, Saastamoinen LK, Korhonen MJ, Enlund H, Helin-Salmivaara A. Impact of restricted 
reimbursement on the use of statins in Finland: a register-based study. Medical care. 2010;48(9):761-6. 
82. Moon J, Godman B, Petzold M, Alvarez-Madrazo S, Bennett K, Bishop I, Bucsics A, Hesse U, Martin A, 
Simoens S, Zara C, Malmstrom RE. Different initiatives across Europe to enhance losartan utilisation post 
generics: impact and implications Frontiers in pharmacology. 2014;5(Article 219):1-10. 
83. Voncina L, Strizrep T, Godman B, Bennie M, Bishop I, Campbell S, et al. Influence of demand-side 
measures to enhance renin-angiotensin prescribing efficiency in Europe: implications for the future. Expert review 
of pharmacoeconomics & outcomes research. 2011;11(4):469-79. 
84. Formoso G, Paltrinieri B, Marata AM, Gagliotti C, Pan A, Moro ML, et al. Feasibility and effectiveness of 
a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial2013. 
85. Furst J, Cizman M, Mrak J, Kos D, Campbell S, Coenen S, et al. The influence of a sustained 
multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and 
implications. Expert review of anti-infective therapy. 2015;13(2):279-89. 
86. Molstad S, Cars O, Struwe J. Strama--a Swedish working model for containment of antibiotic resistance. 
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 
2008;13(46). 
87. Molstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of 
antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. The Lancet 
infectious diseases. 2008;8(2):125-32. 
88. NICE. Respiratory tract infections ± antibiotic prescribing. Prescribing of antibiotics for self-limiting 
respiratory tract infections in adults and children in primary care. Available at URL;  
http://www.nice.org.uk/guidance/cg69/resources/cg69-respiratory-tract-infections-full-guideline3 
89. Russell May J. Advantages of Having Pharmacists on the  Antimicrobial Stewardship Team. Available at 
URL:  http://www.pharmacytimes.com/videos/Advantages-of-Having-Pharmacists-on-the-Antimicrobial-
Stewardship-Team. 
90. Teixeira Rodrigues A, Roque F, Falcao A, Figueiras A, Herdeiro MT. Understanding physician antibiotic 
prescribing behaviour: a systematic review of qualitative studies. International journal of antimicrobial agents. 
2013;41(3):203-12. 
91. Weiss MC, Fitzpatrick R, Scott DK, Goldacre MJ. Pressures on the general practitioner and decisions to 
prescribe. Family practice. 1996;13(5):432-8. 
92. Stivers T, Mangione-Smith R, Elliott MN, McDonald L, Heritage J. Why do physicians think parents 
expect antibiotics? What parents report vs what physicians believe. The Journal of family practice. 
2003;52(2):140-8. 
93. Stivers T. Parent resistance to physicians' treatment recommendations: one resource for initiating a 
negotiation of the treatment decision. Health communication. 2005;18(1):41-74. 
94. Vinson DC, Lutz LJ. The effect of parental expectations on treatment of children with a cough: a report 
from ASPN. The Journal of family practice. 1993;37(1):23-7. 
95. Sarojini S, Faridah A, Lim CM, Sameerah SA, Lim TO, Lai LS, et al. Use of prescription medicines in 
Malaysia 2005. The Medical journal of Malaysia. 2008;63(3):203-6. 
96. Sondergaard J, Vach K, Kragstrup J, Andersen M. Impact of pharmaceutical representative visits on 
GPs' drug preferences. Family practice. 2009;26(3):204-9. 
97. McGettigan P, Golden J, Fryer J, Chan R, Feely J. Prescribers prefer people: The sources of 
information used by doctors for prescribing suggest that the medium is more important than the message. British 
journal of clinical pharmacology. 2001;51(2):184-9. 
98. Civaner M. Sale strategies of pharmaceutical companies in a "pharmerging" country: the problems will 
not improve if the gaps remain. Health policy (Amsterdam, Netherlands). 2012;106(3):225-32. 
99. Davis C, Abraham J. Is there a cure for corporate crime in the drug industry? BMJ (Clinical research ed). 
2013;346:f755. 
100. Ozieranski P, McKee M, King L. Pharmaceutical lobbying under postcommunism: universal or country-
specific methods of securing state drug reimbursement in Poland? Health economics, policy, and law. 
2012;7(2):175-95. 
101. Abraham J. Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions. 
Sociology 2010;44:603-22. 
102. Al-Areefi MA, Hassali MA, Mohamed Ibrahim MI. The role of pharmaceutical marketing and other factors 
in prescribing decisions: the Yemeni experience. Research in social & administrative pharmacy : RSAP. 
2013;9(6):981-8. 
103. Oshikoya KA, Oreagba I, Adeyemi O. Sources of drug information and their influence on the prescribing 
behaviour of doctors in a teaching hospital in Ibadan, Nigeria. The Pan African medical journal. 2011;9:13. 
104. Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from 
pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. 
PLoS medicine. 2010;7(10):e1000352. 
105. Chatterjee S, Patel HK, Sansgiry SS. An analysis of the warning letters issued by the FDA to 
pharmaceutical manufacturers regarding misleading health outcomes claims. Pharm Pract (Granada). 
2012;10(4):194-8. 
106. Yu SY, Yang BM, Kim JH. New anti-rebate legislation in South Korea. Applied health economics and 
health policy. 2013;11(4):311-8. 
107. Godman B, Wettermark B, Hoffmann M, Andersson K, Haycox A, Gustafsson LL. Multifaceted national 
and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert review of 
pharmacoeconomics & outcomes research. 2009;9(1):65-83. 
108. Roehr B. Drug companies will have to report all payments to US doctors from March 2014. BMJ. 
2013;346:f826. 
109. Holbrook A, Lexchin J, Pullenayegum E, Campbell C, Marlow B, Troyan S, et al. What do Canadians 
think about physician-pharmaceutical industry interactions? Health policy (Amsterdam, Netherlands). 
2013;112(3):255-63. 
110. Huttner B, Goossens H, Verheij T, Harbarth S. Characteristics and outcomes of public campaigns aimed 
at improving the use of antibiotics in outpatients in high-income countries. The Lancet infectious diseases. 
2010;10(1):17-31. 
  
 
 
Table 1 Description of studies reporting on knowledge, attitude, beliefs and practices among physicians regarding antibiotic prescribing  
 
Author(s) 
and year 
Country of 
study 
Study design Survey characteristics Response rate/sample 
size 
Study population 
Grossman et 
al (2012) 
A multi-
country 
study 
involving 21 
countries 
from Europe  
Cross-sectional 
web-based 
questionnaire 
   -  69 Questionnaire was pretested 
with national coordinators of 
EAPRASnet (European Academy of 
Pediatrics Research in Ambulatory 
Setting Network), and changes made 
following their comments. 
   - Data collection was carried out 
using a Web-based survey posted on 
European Academy of paediatrics 
homepage. Respondents were invited 
to participate via email using a 
mailing list in EAPRASnet.  
Paediatricians not belonging to the 
network were prompted by the 
Coordinators to visit the hompage 
and fill in the survey. Three 
reminders were sent out via email  
- 695 respondents answered 
the questionnaire; 685 were 
valid responses. 
- 397 were EAPRASnet 
members  and 288 were 
paediatricians visiting the 
web page through the 
embedded link.  
- Primary Care setting 
- Paediatricians and  Physicians 
 - Mean age 50.9 (±7.5 years) 
 - 47.6% female; 52.4% male 
 - Respondents from 21 countries,    
    predominantly from Germany, Spain and  
   Italy (27.3%, 24.7%, 19.4%, respectively) 
  - 86.9% were primary care paediatricians  
    and 13.1%physicians.  
Fakih et al. 
(2003) 
Michigan, 
USA 
Cross-sectional  
Self-completed 
questionnaire 
- Institutional board reviews and 
program directors' approval were 
obtained from graduate medical 
education programs involved in 
internal medicine and family practice 
in southeastern Michigan. Then, the 
survey was mailed to every program 
director to distribute it to their 
resident physicians. 
- Survey included 22 Likert scale-
based questions and 9 multiple-
choice answers. 
- 48% (n=182) from 11 
primary care programs 
responded.  
- They were from Internal 
medicine (IM) 61.6% 
(n=112), family practice 
(FP) 25.8% (n=47), 
emergency medicine (EM) 
10.8% (n=19), and 
medicine-paediatrics (MP) 
2.2% (n=4) 
- Primary care setting 
- 52.5% male; 47.5% female 
- Participating resident physicians were in 
postgraduate years; 
Year 1 (63 residents [34.6%]) 
Year 2 (45 [24.7%]) 
Year 3 (57 [31.3%]) 
Year (8 [4.4%]) 
Cho et al. 
(2004) 
Korea Cross-sectional 
Self-completed 
questionnaire 
 - Using simple random sampling, 
600 physicians from two 
specialties²family practice and 
paediatrics  (300 from each 
specialty). 
 - Questionnaire was pre-tested with 
15 family physicians and 20 
paediatricians.  
- Questionnaires were mailed three 
times with a pre-paid return envelope. 
Follow-up telephone calls were made 
to non-responders.  
75% (n=409) (74.2% for 
family physicians and 75.4% 
for paediatricians) 
- Primary care setting 
 - 75.1% male; 24.9% female 
 - > 90% were solo practitioners in urban areas. 
 - They see approximately 80 patients in a usual 
day 
Pulcini et al. 
(2010) 
France and 
United 
Kingdom 
Cross-sectional 
Self-completed 
questionnaire 
- Survey involved junior doctors in 
two public teaching hospitals; 
Dundee, Scotland, UK and Nice, 
France.  
- Participants were identified using 
data provided by Human Resource 
Department. 
- The questionnaire was developed in 
consultation with a group of experts, 
and was piloted with 10 junior 
doctors.  
- In Dundee, the questionnaires were 
distributed at the beginning of a 
compulsory training session. 
- In Nice, questionnaires were sent by 
email and could be returned by fax, 
E-mail or mail. Reminders emails 
were sent after 3 weeks for non-
responders, and a telephone call 
reminders after 6 weeks.  
73% (n=139) - Hospital setting 
 - 82 participants were from medical specialties, 
and 39 from surgical specialties. 
Thriemer et 
al. (2013) 
DR Congo Cross-sectional 
Self-completed 
questionnaire 
- A Purposive sample of last year 
medical students (who are prescribing 
as part of their practice) and 
prescribing medical doctors 
- Questionnaire was distributed and 
collected by trained collaborators 
 - Medical students were recruited at 
the University Hospital of Kisangani. 
 - Medical doctors were visited on 
site after making an appointment 
 - The respondents filled in the 
questionnaire forms, with 
collaborators available for 
explanation.  
94.4% (n=184) - Hospital and health centers (outpatient) 
setting. 
- Medical doctors and medical students 
accounted for 78 (42.3%) and 106 (57.6%) of 
respondents respectively. 
- Among medical doctors, 11.5% (n=11) has 
less than 1 year work experience; 38.5% 1-3 
years; 23.1% 4-6 years; 26.9% more than 10 
years. 
- 54.4% prescribed antibiotics more than once a 
day; 15.2% 1-2 times; 17.4% 3-5 times per 
week. 
-  
Butler et al. 
(1998) 
South 
Wales, UK 
Qualitative 
study with semi-
structured 
interviews 
- A sampling frame was constructed 
to identify the general practitioners 
(GPs) according to their size of 
practices.  
- Interviews were conducted with 
GPs and lasted 10-35 minutes. 
- The semi-structured interviews were 
piloted with four GPs.  
- All questions were open. New 
questions were added as the 
interviews progressed. When no new 
themes emerged, the interviews were 
ended.  
21 GPs recruited - Primary care setting 
- 17 of the GPs had qualified in Britain, 13 held 
MRCGP, working experience between one and 
28 years.  
Sutradhar et 
al. (2014) 
Bangladesh Cross-sectional  
Self-completed 
questionnaire 
- The survey was done in 24 Upazila 
Health Complexes and 112 Union 
Health Centers of Dhaka and Rajashi 
divisions.  
- Questionnaires were pilot-tested 
prior to the main survey. 
- The survey was done by 
inteviewers, following a face-to-face 
interview protocol.  
- Questionnaires were given only to 
the spontaneously interested 
candidates during the survey.  
580 physicians - Outpatient setting (health centers) 
 - Registered physicians  practicing in the 
Upazila Health Complexes and Union Health 
Centers  
Srinisavan et 
al. (2004) 
Baltimore, 
USA 
Cross-sectional  
Self-completed 
questionnaire 
- A 75-item survey was developed, 
including 10-item antimicrobial quiz. 
- The survey was administered to the 
house staff physicians at John Hopkin 
Hospital. 
- Surveys were distributed on campus 
and by electronic mail to the 
participants. 
- Surveys were re-sent every 2 and 4 
week for those who had not returned 
them.  
- 67% (n=179) responded as 
follows:  
 - General medicine 86 
(83%),       
 -Emergency medicine 
23(64%) 
 - Obe/Gyn 15 (50%) 
 - Surgery 40 (48%) 
  - Neurology 5 (33%) 
- Hospital setting 
- 32% was in the first year of residency; 23% 
second year; 31% third year; 13% beyond that.  
- Emergency house staff prescribed antibiotics 
the most (78% prescribing more than once a 
day;33% Ob/Gyn; 25% surgery; 20% 
medicine)  
Mohan et al. 
(2004) 
Trinidad and 
Tobago 
Cross-sectional 
Self-completed 
questionnaire 
- Questionnaires were distributed 
among GPs from central and east 
Trinidad, from the respective 
branches of the Trinidad and Tobago 
Medical Association. 
- Letters were mailed to the doctors 
followed by telephone calls inviting 
them to participate.  
84.4% (n=92) - Primary care setting 
 - Doctors working in primary healthcare in the 
public sector were excluded. 
- 88% male (81); 12% (11) female.  -  - Mean 
age: 52.55 years  
 - 26.1% had >30 years of practice;  41.3% less 
than 20 years 
Garcia et al. 
(2011)  
Peru Cross-sectional 
Self-completed 
questionnaire 
- The Survey was done with residents 
(physicians in training) and attending 
physicians ( staff physicians) from 
two public hospitals, Cayetano 
Heredia (CHH) and Arzobispo 
Loayza (ALH), both are tertiary, 
teaching hospital located in urban 
areas.  
- Questionnaire content was based on 
a previous survey in US, adapted into 
Peruvian system. Prior to 
administration, it was reviewed by a 
team of 6 infectious disease 
physicians.  
82% (n=260) - Hospital setting 
- 53% (135) residents (physicians in training) 
and 47% (121) attending physicians ( staff 
physicians after completing training and 
specialization) 
- 55% of respondents has less than 5 years 
working experience 
 
  
Chandy et al. 
(2013) 
South India, 
India 
Qualitative 
study using 
focus group 
discussion 
(FGD) 
- Recruitment was done through 
purposive sampling. Open invitations 
were given through respective 
associations, selection based on their 
willingness and ability to commit 
time for the FGD.  
- Discussion was guided by a 
moderator, who communicated the 
objective of the discussion, and used 
a semi-structured discussion guide 
with predefined themes.  
Two groups of 6 doctors 
each, from urban and rural 
area. 
- Doctors were mainly in private practice and 
hospital, from urban and rural areas.  
- Age range for urban doctors: 33-63 years, 
while 29-54 for rural doctors. 
Woods et al. 
(2013) 
A multi-
country 
study from 
Europe   
Qualitative 
study, using a 
semi-structured 
interview and a 
fixed category 
survey 
- Primary care clinicians were 
selected randomly from Genomics to 
combat Resistance against 
communiti-acquired LRTI in Europe 
(GRACE). 
- Interviews were conducted by a 
trained interviewer. A pre-piloted 
interview topic guide was used to 
facilitate the interviews. 
80 interviews were 
conducted.  
- 41%  were female participant.  
 - Mean age 43 years. 
 - Mean years in practice; 16 years 
Zaki et al. 
(2012) 
Sudan Cross-sectional 
hospital based 
interview study  
- Participants were selected randomly 
from private and governmental 
hospitals.  
- The survey used a 16-item 
antimicrobial quiz questionnaire.  
72.4% (n=181) - 86.7% practitioners were from governmental 
hospital while 13.3% practitioners were from 
private hospitals.  
Chamani et 
al. (2005) 
USA Cross-sectional 
self-completed 
questionnaire 
- Questionnaires were distributed 
among American College of 
Obtetricians and Gynecologists 
(ACOG) Fellows.  
- Questionnaires were sent by mail. 
Non-responders received second 
mailing after 6 weeks of first mailing.  
48% (n=428) Obstetricians and Gynecologists in 
ambulatory settings within USA who manage 
upper respiratory tract infections (URIs) in 
non-pregnant patients.  
Navarro-San 
Francisco et 
al. (2013) 
Spain Cross-sectional 
self-completed 
questionnaire 
- The survey was conducted with all 
resident doctors in 5 teaching 
hospitals in 4 different cities (Madrid, 
Sevile, Murcia and Barakaldo) 
- This is an online survey. A link to 
the questionnaire was emailed to all 
33.05% (n=279) 844 residents in various specialties 
participants.  
- Residents received 3 reminders 
during the 8 weeks of survey 
Vazquez 
Lago et al. 
(2011) 
Spain Qualitative 
study using 
focus group 
discussion 
(FGD) 
- The study used a theoretical model 
based on previous systematic review. 
- Participants were recruited with the 
support of Galician Association of 
Family and Community Medicine. 
Potential participants were contacted 
by telephone or email. 
- Each FG was made of 4-10 GPs, 
sessions were held in the meeting 
room at the respective health centers 
at the time reserved for teaching 
activities.  
44% (n=33) 
 
- GPs in the Spanish NHS in Galicia actively 
engaged in healthcare.  
 
- 14 female (42.4%) and 19 male (57.6%) 
Kotwani et 
al. (2010) 
India Qualitative 
study using 
focus group 
discussion 
(FGD) 
- Three FGD conducted; 1 group 
composed exclusively doctors from 
private sectors, one group for public 
sector doctors and the third group 
contained doctors from both sectors.  
- The FGDs was conducted with the 
help of a topic guide.  
- Results from a completed antibiotic 
use and resistance study were given 
to participants at the beginning of 
FGDs.  
36 doctors participated in 3 
FGDs 
Primary care doctors practicing in both private 
and public sectors 
Adorka et al. 
(2013) 
Lesotho Cross-sectional 
self-completed 
questionnaire 
- The survey was conducted in 5 
Health Service Areas in Lesotho. 
- Questionnaires were distributed and 
collected by the principal researcher.  
76% (n=51) All doctors and nurses who prescribed 
antibiotics.  
Wester et al. 
(2002) 
Chicago, 
USA 
Cross-sectional 
self -completed 
questionnaire 
- The survey was conducted in 4 
Chicago hospitals.  
- A 94-item self-administered 
questionnaire was used to collect 
information.Questionnaires were 
distributed among prescribers. After 
2 weeks, phone calls were made to 
remind non-respondents.  
87% (n=424) Physicians included: All internal medicine 
residents and attending physicians, who cared 
for a minimum of 60 inpatients in that year. 
(excluding cardiologist and neurologist) 
  
